0.05Open0.05Pre Close0 Volume85 Open Interest2.50Strike Price0.00Turnover300.56%IV137.21%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1724Delta0.3597Gamma21.50Leverage Ratio-0.0051Theta0.0001Rho3.71Eff Leverage0.0006Vega
Connect Biopharma Stock Discussion
NEWS
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
Price target for this stock is 7$ its undervalued .. sooner it will jump to 2.5 to 3$
No comment yet